New IGF drug stirs competition in growth factor segment
Article Abstract:
The US Food and Drug Administration (FDA) in 2005 approved Tercica's Increlex recombinant human IGF-1 as a long-term treatment for children with severe primary IGF-1 deficiency (IGFD) as it is the principal mediator of both cartilage and bone growth in the body. A deficiency of IGF-1 results in impaired growth and is associated with metabolic abnormalities including insulin resistance, increased adiposity and delayed wound healing.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Nature biotechnology: Lost in validation
Article Abstract:
The pharmaceutical industry has seen an increase in molecular diagnostics and pharmacogenetic test disease-associated molecular markers, but only a handful of diagnostic tests have passed approval by regulatory agencies. The absence of established, standardized means for validating the association between a marker and clinical outcomes is cited as the cause for such situation.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design
Article Abstract:
A family of potent phophodiesterases (PDE) 4 inhibitors discovered using an efficient method for scaffold-based drug design is described. It involves an iteration approach starting with low-affinity screening of compounds followed by high-throughput cocrystallography to reveal the molecular basis underlying the activity of the newly identified compounds.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: How to conduct competitive intelligence in your biotech startup. The role of competitive intelligence in biotech startups
- Abstracts: Customer-based corporate reputation of a service firm: scale development and validation. Psychological climate, empowerment, leadership style, and customer-oriented selling: an analysis of the sales manager- salesperson dyad
- Abstracts: A new role for scientists in the biological weapons convention. Overhauling oversight: European drug legislation
- Abstracts: Why is UK unemployment rising? Pulp fiction. Another great British empire
- Abstracts: Another brick in the wall. Talking and walking. The schmoozing ruse